Amy Pott - 16 Jun 2025 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Reporting relationship: Chief Global Comm. Ofc.
Issuer ticker: ENGN
Reported as of: 16 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2025, 18:40:07 UTC
Prior SEC filing: 29 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Lee Giguere, as attorney-in-fact for the Reporting Person

Key filing fact

Amy Pott filed Form 4 for enGene Holdings Inc. (ENGN) on 16 Jun 2025.

Key facts

This page summarizes Amy Pott's Form 4 filing for enGene Holdings Inc. (ENGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2025, 18:40.

Change

Previous filing in this sequence was filed on 29 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001787363 Primary reporting owner

Pott Amy

Relationship: Chief Global Comm. Ofc.
Address: C/O 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, QUEBEC, CANADA
Signature: /s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Signature date: 16 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENGN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +400,000
Change %
Price: $0.000000
Shares after: 400,000
Date: 16 Jun 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 400,000
Exercise price: $3.31
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Non-qualified stock option grant awarded as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on May 27, 2026, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the remaining three years, subject to the reporting person's continued service.